Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin vs Carboplatin in Neoadjuvant HER2+ Breast Cancer
NCT07093931Phase 4Not yet recruiting
- Sponsor
- Shandong Cancer Hospital
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lobaplatin in breast cancer, sponsored by Shandong Cancer Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
lobaplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07093931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093931.